Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer
作者： Kevin J. Donohoe , Jennifer Aloff , Anca M. Avram , K.G. Bennet , Luca Giovanella
DOI: 10.2967/JNUMED.119.240945
关键词:
摘要: Nuclear medicine is an essential tool in the delivery of high-quality medical care, going beyond simple anatomic imaging to use physiologic processes for both and therapy. One first uses nuclear techniques occurred 1930s demonstrate physiology
elsevier.com
sci-hub.se 参考文章(141)
Maythinee Chantadisai, Kanaungnit Kingpetch, Usefulness of 99mTc-pertechnetate whole body scan with neck and chest SPECT/CT for detection of post-surgical thyroid remnant and metastasis in differentiated thyroid cancer patients Annals of Nuclear Medicine. ,vol. 28, pp. 674- 682 ,(2014) , 10.1007/S12149-014-0864-3
Orsolya Dohan, Antonio De la Vieja, Viktoriya Paroder, Claudia Riedel, Mona Artani, Mia Reed, Christopher S Ginter, Nancy Carrasco, None, The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. Endocrine Reviews. ,vol. 24, pp. 48- 77 ,(2003) , 10.1210/ER.2001-0029
Ernest L. Mazzaferri, Richard T. Kloos, Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer The Journal of Clinical Endocrinology and Metabolism. ,vol. 86, pp. 1447- 1463 ,(2001) , 10.1210/JCEM.86.4.7407
E. B. Silberstein, Comparison of Outcomes After 123I Versus 131I Preablation Imaging Before Radioiodine Ablation in Differentiated Thyroid Carcinoma The Journal of Nuclear Medicine. ,vol. 48, pp. 1043- 1046 ,(2007) , 10.2967/JNUMED.107.040311
Katherine S. Kolbert, George Sgouros, George Sgouros, Keith S. Pentlow, Richard J. Robbins, Steven M. Larson, Edward F. Mun, Arif Sheikh, Axel Barth, Patient-Specific Dosimetry for 131I Thyroid Cancer Therapy Using 124I PET and 3-Dimensional-Internal Dosimetry (3D-ID) Software The Journal of Nuclear Medicine. ,vol. 45, pp. 1366- 1372 ,(2004)
Penny F Whiting, Anne WS Rutjes, Marie E Westwood, Susan Mallett, Jonathan J Deeks, Johannes B Reitsma, Mariska MG Leeflang, Jonathan AC Sterne, Patrick MM Bossuyt, QUADAS-2 Group*, None, QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies Annals of Internal Medicine. ,vol. 155, pp. 529- 536 ,(2011) , 10.7326/0003-4819-155-8-201110180-00009
Gregory W. Randolph, Gilbert H. Daniels, Radioactive Iodine Lobe Ablation as an Alternative to Completion Thyroidectomy for Follicular Carcinoma of the Thyroid Thyroid. ,vol. 12, pp. 989- 996 ,(2002) , 10.1089/105072502320908321
K K WONG, N ZARZHEVSKY, J M CAHILL, K A FREY, A M AVRAM, Hybrid SPECT–CT and PET–CT imaging of differentiated thyroid carcinoma British Journal of Radiology. ,vol. 82, pp. 860- 876 ,(2009) , 10.1259/BJR/25645894
L. Chen, Q. Luo, Y. Shen, Y. Yu, Z. Yuan, H. Lu, R. Zhu, Incremental Value of 131I SPECT/CT in the Management of Patients with Differentiated Thyroid Carcinoma The Journal of Nuclear Medicine. ,vol. 49, pp. 1952- 1957 ,(2008) , 10.2967/JNUMED.108.052399
D. Deandreis, A. Al Ghuzlan, S. Leboulleux, L. Lacroix, J. P. Garsi, M. Talbot, J. Lumbroso, E. Baudin, B. Caillou, J. M. Bidart, M. Schlumberger, Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome? Endocrine-related Cancer. ,vol. 18, pp. 159- 169 ,(2011) , 10.1677/ERC-10-0233